[go: up one dir, main page]

MX2016012485A - Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina. - Google Patents

Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.

Info

Publication number
MX2016012485A
MX2016012485A MX2016012485A MX2016012485A MX2016012485A MX 2016012485 A MX2016012485 A MX 2016012485A MX 2016012485 A MX2016012485 A MX 2016012485A MX 2016012485 A MX2016012485 A MX 2016012485A MX 2016012485 A MX2016012485 A MX 2016012485A
Authority
MX
Mexico
Prior art keywords
pyridin
phenyl
aminocyclobutyl
imidazo
amine
Prior art date
Application number
MX2016012485A
Other languages
English (en)
Other versions
MX367267B (es
Inventor
P Reed David
Mao Jianmin
Xie Chen Jian-
Bates Craig
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of MX2016012485A publication Critical patent/MX2016012485A/es
Publication of MX367267B publication Critical patent/MX367267B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se dirige a procesos para la síntesis de 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3H-imidazo[4,5-b]piridi n-2-il)piridin-2-amina (ver Fórmula).
MX2016012485A 2014-03-24 2015-03-24 Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina. MX367267B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461969546P 2014-03-24 2014-03-24
PCT/US2015/022177 WO2015148464A1 (en) 2014-03-24 2015-03-24 Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

Publications (2)

Publication Number Publication Date
MX2016012485A true MX2016012485A (es) 2016-12-16
MX367267B MX367267B (es) 2019-08-12

Family

ID=54141455

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012485A MX367267B (es) 2014-03-24 2015-03-24 Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.

Country Status (16)

Country Link
US (2) US9464083B2 (es)
EP (1) EP3122748B1 (es)
JP (1) JP6578298B2 (es)
KR (1) KR20160135234A (es)
CN (1) CN106459036B (es)
AU (1) AU2015236273B2 (es)
BR (1) BR112016021910A2 (es)
CA (1) CA2938923A1 (es)
DK (1) DK3122748T3 (es)
ES (1) ES2692243T3 (es)
IL (2) IL247480A (es)
MX (1) MX367267B (es)
RU (1) RU2677478C2 (es)
TW (1) TWI662033B (es)
WO (1) WO2015148464A1 (es)
ZA (1) ZA201605598B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013430A2 (en) 2016-07-12 2018-01-18 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus infection
WO2019027856A1 (en) * 2017-08-02 2019-02-07 Merck Sharp & Dohme Corp. NOVEL SUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO)
US11208407B2 (en) 2017-08-02 2021-12-28 Merck Sharp & Dohme Corp. Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection
WO2023168291A1 (en) * 2022-03-02 2023-09-07 Terremoto Biosciences, Inc. Covalent modifiers of akt1 and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
CN1173975C (zh) * 2000-04-27 2004-11-03 山之内制药株式会社 咪唑并吡啶衍生物
US6403588B1 (en) 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
SG131944A1 (en) * 2003-08-21 2007-05-28 Osi Pharm Inc N3-substituted imidazopyridine-derivatives as c-kit inhibitors
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
RU2008141761A (ru) * 2006-03-22 2010-04-27 Вертекс Фармасьютикалз Инкорпорейтед (Us) ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ
SG181947A1 (en) * 2009-12-30 2012-07-30 Arqule Inc Substituted imidazopyridinyl-aminopyridine compounds
JP5959330B2 (ja) * 2011-06-17 2016-08-02 田辺三菱製薬株式会社 新規抗血小板薬
WO2012177852A1 (en) 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
KR20190015600A (ko) 2011-06-24 2019-02-13 아르퀼 인코포레이티드 치환된 이미다조피리디닐-아미노피리딘 화합물
WO2013078254A1 (en) * 2011-11-22 2013-05-30 Array Biopharma Inc. Bicyclic heteroaryl derivatives as kinase inhibitors

Also Published As

Publication number Publication date
CA2938923A1 (en) 2015-10-01
BR112016021910A2 (pt) 2017-08-15
CN106459036B (zh) 2021-07-16
US9464083B2 (en) 2016-10-11
ZA201605598B (en) 2018-12-19
CN106459036A (zh) 2017-02-22
IL253239B (en) 2018-04-30
IL253239A0 (en) 2017-08-31
JP6578298B2 (ja) 2019-09-18
EP3122748B1 (en) 2018-09-26
ES2692243T3 (es) 2018-11-30
RU2016141426A3 (es) 2018-11-19
DK3122748T3 (en) 2018-11-05
AU2015236273B2 (en) 2019-03-28
TWI662033B (zh) 2019-06-11
EP3122748A1 (en) 2017-02-01
US20160376270A1 (en) 2016-12-29
TW201623301A (zh) 2016-07-01
US9834556B2 (en) 2017-12-05
RU2677478C2 (ru) 2019-01-17
US20150266876A1 (en) 2015-09-24
KR20160135234A (ko) 2016-11-25
EP3122748A4 (en) 2017-09-27
WO2015148464A1 (en) 2015-10-01
IL247480A (en) 2017-07-31
AU2015236273A1 (en) 2016-08-25
JP2017516749A (ja) 2017-06-22
RU2016141426A (ru) 2018-04-25
MX367267B (es) 2019-08-12

Similar Documents

Publication Publication Date Title
TW201129555A (en) Process for the manufacture of dabigatrane etexilate
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
JOP20170101B1 (ar) توليف مركبات إندازول
MX367267B (es) Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
PH12014501712B1 (en) Novel morpholinyl derivatives useful as mogat-2-inhibitors
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
IN2014MU01192A (es)
IN2014MU00195A (es)
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
MX375758B (es) Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido.
IN2014MU00194A (es)
IN2014MU01196A (es)
NZ728915A (en) Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochloride
IN2014CH00444A (es)
IN2014MU00072A (es)
MX364769B (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
MX2016010549A (es) Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas.
IN2014MU00858A (es)
IN2014MU01195A (es)
MY190171A (en) Synthesis of indazoles
IN2013CH05863A (es)
IN2013MU01524A (es)
MX365384B (es) Metodo de sintesis de derivados de 9-alilcamptotecina.

Legal Events

Date Code Title Description
FG Grant or registration